-+ 0.00%
-+ 0.00%
-+ 0.00%

NRx Pharmaceuticals names Glenn Tyson as first chief commercial officer

PUBT·04/13/2026 11:01:55
Listen to the news
NRx Pharmaceuticals names Glenn Tyson as first chief commercial officer
  • NRx Pharmaceuticals appointed Glenn Tyson as its first chief commercial officer.
  • Tyson previously held senior commercial roles at GSK, Indivior, Transcend Therapeutics.
  • NRx plans to build market access, distribution, sales, marketing ahead of expected approval of its preservative-free ketamine ANDA.
  • Commercial push also targets near-term New Drug Application submission to expand IV ketamine labeling to depression, suicidality.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NRX Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604130700PRIMZONEFULLFEED9688165) on April 13, 2026, and is solely responsible for the information contained therein.